Judge Finds Novo's Prandin Patent Invalid
By Abigail Rubenstein · January 19, 2011, 3:36 PM EST
A federal judge Wednesday found the patent for Novo Nordisk A/S diabetes drug Prandin invalid because of obviousness and unenforceable due to inequitable conduct, paving the way for Caraco Pharmaceutical Laboratories...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login